Barclays PLC
05 July 2005
Absa Group Limited
(Registration number 1986/003934/06)
(Incorporated in the Republic of South Africa)
JSE share code: ASA
ISIN: ZAE000013389
('Absa')
Barclays Bank PLC
(Registration number 1026167)
(Incorporated in England)
('Barclays')
POSTPONEMENT OF COURT HEARING
1. Introduction
Shareholders are referred to the joint announcements released on 9 May 2005
and 21 June 2005, the SENS announcement released on 4 July 2005 and the
circular to shareholders dated 20 May 2005 (the 'Circular') regarding the
Barclays proposed acquisition of up to 60% of the Absa ordinary shares at
R82.50 per share (the 'Recommended Acquisition'). Shareholders are reminded
that the Recommended Acquisition is being effected through two
inter-conditional processes:
(i) the scheme of arrangement proposed by Barclays between Absa and the Absa
Ordinary Shareholders, excluding the Absa Group Limited Share Incentive
Scheme Trust and the Barclays Group (save to the extent that members of
that group may hold Absa Ordinary Shares on behalf of third parties),
pursuant to which Barclays will acquire 32% of each such Ordinary
Shareholder's shares (the 'Scheme'); and
(ii) the partial offer by Barclays to all Absa Ordinary Shareholders and
Preference Shareholders (together 'Shareholders') to acquire from each
such Shareholder an additional 28% of his or her shares (the 'Recommended
Offer').
Shareholders of Absa are advised that:
* at the meeting held on Monday, 13 June 2005, the requisite majority of
Absa shareholders approved the Scheme; and
* the Recommended Offer was declared unconditional as to acceptances on
Monday, 4 July 2005.
2. Postponement of court hearing
At the hearing to sanction the Scheme held today at the High Court of South
Africa (Witwatersrand Local Division) (the 'Court'), three parties raised
opposition to the sanctioning of the Scheme. The Court has postponed the hearing
of the matter until tomorrow (Wednesday, 6 July 2005) to allow more time for the
preparation of arguments. There has been no argument on the merits of the case.
Absa and Barclays remain confident that the Scheme will be sanctioned.
At this stage the timetable of the Recommended Acquisition remains unchanged. If
there is a change to the timetable it will be announced.
For further information, please contact:
Absa Group Limited Barclays PLC
Investor Relations Investor Relations
Willie Roux Mark Merson/James Johnson
+27 (0) 11 350 4061 +44 (0) 20 7116 5752/2927
Media Relations Media Relations - London
Nick Cairns Chris Tucker
+27 (0) 11 350 6565 +44 (0) 20 7116 6223
Media Relations - Johannesburg
Liz Hooper
+27 (0) 11 328 3160
Johannesburg
5 July 2005
Financial advisors to Absa Financial advisors to Barclays
Goldman Sachs International JP Morgan
Merrill Lynch International Barclays Capital
Absa Corporate & Merchant Bank
Attorneys to Absa Attorneys to Barclays
Webber Wentzel Bowens Deneys Reitz Inc.
International Attorneys to Absa International Attorneys to Barclays
Linklaters Clifford Chance LLP
Independent Advisor to Absa's Board
N.M. Rothschild
Sponsor to Absa
Merrill Lynch South Africa (Pty) Ltd
Co-sponsor to Absa
Absa Corporate & Merchant Bank
Reporting Accountants to Absa
Ernst & Young
KPMG
This information is provided by RNS
The company news service from the London Stock Exchange
EASXSEFESEFE
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.